Brief: Igea Pharma H1 Net Loss Down At TUSD 547.3

IGEA Pharma NV

03/09/2020 06:50

Sept 3 (Reuters) - IGEA PHARMA NV  IGPH.S :
    * SAID ON WEDNESDAY H1 COST OF REVENUE TUSD 138.4 (PREVIOUS
PERIOD: TUSD 172.4)
    * H1 OPERATING EXPENSES TUSD 444.4 (PREVIOUS PERIOD: TUSD
779.0)
    * H1 NET LOSS TUSD 547.3 (PREVIOUS PERIOD: TUSD 946.9)

    
 Source text for Eikon:  ID:nEQ7GRZqZa 
    
 Further company coverage:  IGPH.S  
   


 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))